<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dipfluzine (Dip) is a novel diphenylpiperazine <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi> first synthesized in China </plain></SENT>
<SENT sid="1" pm="."><plain>Effects of Dip on experimental <z:mp ids='MP_0005048'>thrombosis</z:mp> and platelet aggregation were studied in vitro and in vivo compared with <z:chebi fb="0" ids="31403">cinnarizine</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Cin</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Dip 1 and 2 mg.kg-1 i.v. and incubated in 1-100 mumol.L-1 in vitro inhibited dose- or concentration-dependent rabbit platelet aggregation induced by <z:chebi fb="13" ids="16761">ADP</z:chebi> and by <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> (AA), respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Dip 2.5-10 mg.kg-1 i.v. and 50-100 mg.kg-1 ip inhibited the <z:mp ids='MP_0005048'>thrombosis</z:mp> in rats </plain></SENT>
<SENT sid="4" pm="."><plain>Dip 10 mg.kg-1 i.v. and 200 mumol.L-1 depressed the in vitro <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest that attenuation of disturbed platelet-vessel wall reaction associated with platelet activation and vasoconstriction may be a main factor involved in the antithrombotic action of Dip, and that the effects of Dip were more potent than those of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Cin</z:e> </plain></SENT>
</text></document>